奥格雷摩芬抑制了GPR68介导的MUC5AC表达
Leif R Neitzel1,2, Hussain F Basrai1,2, Charles C Hong1,2
1Medicine, Michigan State University, East Lansing, Michigan, United States.
microPublication biology
|October 6, 2025
概括
用Ogremorphin (OGM) 准GPR68受体可以减少MUC5AC粘液的产生. 这一发现为改善呼吸道清除和抑制瘤进展提供了对肺部疾病的潜在治疗方法.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 肺部医学 肺部医学
背景情况:
- 粘液过分分泌,特别是MUC5AC,在喘等肺部疾病中加重呼吸道阻塞,并有助于瘤生长.
- 感应pH的受体GPR68是MUC5AC表达的关键调节器.
研究的目的:
- 研究GPR68在酸性条件下调解MUC5AC表达中的作用.
- 评估GPR68抑制剂Ogremorphin (OGM) 在降低MUC5AC产生的疗效.
主要方法:
- 利用A549肺癌细胞研究MUC5AC mRNA和蛋白质表达.
- 应用了酸性条件 (pH 6.4) 和用转基因生物处理的细胞.
- 使用shRNA介导的淘汰方法确认了GPR68的作用.
主要成果:
- 酸化 (pH 6.4) 显著增加了MUC5AC mRNA和蛋白质水平,以依赖于GPR68的方式.
- 转基因转基因治疗有效降低了MUC5AC表达,独立于pH值.
- GPR68的淘汰证实了转基因生物对MUC5AC生产的抑制作用.
结论:
- 对于MUC5AC的高分泌,GPR68的信号传递至关重要.
- 通过转基因生物来抑制GPR68是一种有前途的治疗策略,用于控制肺部疾病中的粘液过分分泌.
- 这种方法可以改善气道清除,并限制肺部疾病中的瘤进展.
相关概念视频
GPCR Desensitization
7.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
Opioid Receptors: Overview
4.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.0K
Cholinergic Receptors: Muscarinic
4.8K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
4.8K
Activation and Inactivation of G Proteins
10.9K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
10.9K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.1K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.1K


